The impact of the Highmark employee wellness programs on 4-year healthcare costs

被引:104
作者
Naydeck, Barbara L. [1 ]
Pearson, Janine A.
Ozminkowski, Ronald J. [4 ]
Day, Brian T. [1 ]
Goetzel, Ron Z. [2 ,3 ]
机构
[1] Highmark Inc, Pittsburgh, PA 15222 USA
[2] Emory Univ, Inst Hlth & Prod Studies, Washington, DC USA
[3] Thomson Hlthcare, Hlth & Prod Res, Washington, DC USA
[4] Hlth Econ, Ann Arbor, MI USA
关键词
D O I
10.1097/JOM.0b013e3181617855
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: To determine the return on investment (ROI) of Highmark Inc.'s employee wellness programs. Methods: Growth curve analyses compared medical claims for participants of wellness programs versus risk-matched nonparticipants for years 2001 to 2005. The difference was used to define savings. ROI was determined by subtracting program costs from savings and alternative discount rates were applied in a sensitivity analysis. Results: Multivariate models estimated health care expenses per person per year as $176 lower for participants. Inpatient expenses were lower by $182. Four-year savings of $1,335,524 compared with program expenses of $808,403 yielded an ROI of $1.65 for every dollar spent on the program. Conclusions: Using sophisticated methodology, this study suggests that a comprehensive health promotion program can lower the rate of health care cost increases and produce a positive ROI.
引用
收藏
页码:146 / 156
页数:11
相关论文
共 24 条
[1]   Financial impact of health promotion programs: A comprehensive review of the literature [J].
Aldana, SG .
AMERICAN JOURNAL OF HEALTH PROMOTION, 2001, 15 (05) :296-320
[2]  
*AWHP, 1999, 1999 NAT WORKS HLTH
[3]  
BERGSTRALH EJ, 1995, 56 MAY FDN
[4]  
*BUR LAB STAT, INS CARR REL ACT OCC
[5]  
*CDCP, 2007, HLTH WORKS IN
[6]  
Chapman LS, 2005, AM J HEALTH PROMOT, V19, P1
[7]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[8]   ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES [J].
DEYO, RA ;
CHERKIN, DC ;
CIOL, MA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :613-619
[9]   Practical considerations on the use of the Charlson comorbidity index with administrative data bases [J].
DHoore, W ;
Bouckaert, A ;
Tilquin, C .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1996, 49 (12) :1429-1433
[10]  
Duan N., 1983, J EC BUSINESS STATIS, V1, P115, DOI [DOI 10.2307/1391852, DOI 10.1080/07350015.1983.10509330]